It is a veterinary private limited company based in Bangalore, Karnataka, India, established in 2017.
2017 | Bangalore, Karnataka, India | Struck OffPeregrine Cancer Cure Technologies Private Limited, a struck off private limited company, was established on 08 September 2017 in Bangalore, Karnataka, India. Engaging in animal health services within the veterinary sector, it holds CIN: U85200KA2017PTC106245. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Soumya Rengarajan (Director), Balachander Agoramurthy (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No.107, B Block, Aban Essence, 1St Floor S.No.60, Kudlu Village, Madiwala Post, Bangalore, Karnataka, 560068.
U85200KA2017PTC106245
106245
08 September 2017
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Peregrine Cancer Cure Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soumya Rengarajan | Director | 08 Sep 2017 | Current |
| Balachander Agoramurthy | Director | 08 Sep 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Peregrine Cancer Cure Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 196.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Peregrine Cancer Cure Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Peregrine Cancer Cure Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Peregrine Cancer Cure Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peregrine Cancer Cure Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Peregrine Cancer Cure Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Peregrine Cancer Cure Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was completed.
The activity Soumya Rengarajan was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 8 years 3 months . was completed.
Balachander Agoramurthy was appointed as a Director was appointed as a Director on 08 Sep 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
Progress on Peregrine Cancer Cure Technologies Private Limited was registered on 08 Sep 2017 with Roc Bangalore & aged 8 years 3 months as per MCA records. was documented.
The CIN of Peregrine Cancer Cure Technologies Private Limited is U85200KA2017PTC106245.
Peregrine Cancer Cure Technologies Private Limited is headquartered at No.107, B Block, Aban Essence, 1St Floor S.No.60, Kudlu Village, Madiwala Post, Bangalore, Karnataka, 560068.
Peregrine Cancer Cure Technologies Private Limited was incorporated on 08 September 2017.
The current directors of Peregrine Cancer Cure Technologies Private Limited are
The primary industry of Peregrine Cancer Cure Technologies Private Limited is Veterinary.
Peregrine Cancer Cure Technologies Private Limited is unlisted.
The authorized capital of Peregrine Cancer Cure Technologies Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Peregrine Cancer Cure Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX